TILATAMIG
UNII Y5RC3BF6LQ

Substance Identification & Data

This profile provides standardized clinical and technical data for Tilatamig, uniquely identified by the FDA Unique Ingredient Identifier (UNII) Y5RC3BF6LQ.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 2868265-50-1 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

Y5RC3BF6LQ

CAS Registry Number

2868265-50-1

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

TILATAMIG

Official standardized name for this substance within the FDA UNII nomenclature system.

NCI Thesaurus

C207004

National Cancer Institute reference terminology for clinical and research data.

INN ID

13020

Sequential identifier assigned via the WHO International Nonproprietary Name program.

USAN ID

NO-13

Identifier assigned by the United States Adopted Names Council.

Substance Type

protein

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Tilatamig. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

TILATAMIG

Common Names & Synonyms

IMMUNOGLOBULIN G1 (133-CYSTEINE,227-VALINE,241-PHENYLALANINE,242-GLUTAMIC ACID,338-SERINE,361-CYSTEINE,373-TRYPTOPHAN), ANTI-(HUMAN EPIDERMAL GROWTH FACTOR RECEPTOR) (HUMAN MONOCLONAL RAA22 .GAMMA.1-CHAIN), (133->126'')-DISULFIDE WITH (126-CYSTEINE,216-VALINE) HUMAN MONOCLONAL RAA22 .LAMBDA.-CHAIN, (233->225'),(236->228'),(361->348')-TRIS(DISULFIDE) WITH IMMUNOGLOBULIN G1 (233-PHENYLALANINE,234-GLUTAMIC ACID,330-SERINE,348-CYSTEINE,365-SERINE,367-ALANINE,406-VALINE) ANTI-(HUMAN HEPATOCYTE GROWTH FACTOR RECEPTOR C-MET) (HUMAN MONOCLONAL B09 .GAMMA.1-CHAIN) DISULFIDE WITH HUMAN MONOCLONAL B09 .KAPPA.-CHAIN

IMMUNOGLOBULIN G1-KAPPA/G1-LAMBDA, ANTI-(HOMO SAPIENS MET (MET PROTO-ONCOGENE, HEPATOCYTE GROWTH FACTOR (HGF) RECEPTOR, HGFR, SCATTER FACTOR (SF) RECEPTOR, HGF/SF RECEPTOR, RECEPTOR TYROSINE-PROTEIN KINASE C-MET, PAPILLARY RENAL CELL CARCINOMA 2, RCCP2)) AND ANTI-(HOMO SAPIENS EGFR (EPIDERMAL GROWTH FACTOR RECEPTOR, RECEPTOR TYROSINE-PROTEIN KINASE ERBB-1, ERBB1, HER1, HER-1, ERBB)), HOMO SAPIENS MONOCLONAL ANTIBODY, BISPECIFIC

TILATAMIG [INN]

TILATAMIG [USAN]

External Clinical & Regulatory Resources

Previous UNIIY5R8PB2RGB

Next UNIIY5RJ1NJL38